Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Immune Thrombocytopenia
Related studies linked through entity extraction aliases.
Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia
- Status
- RECRUITING
- Phase
- N/A
CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2
An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
- Status
- COMPLETED
- Phase
- PHASE2
Biologic Characterization of Patients With ITP
- Status
- RECRUITING
- Phase
- NA
Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE3
Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies
- Status
- UNKNOWN
- Phase
- N/A
IVIg Plus Low Dose rhTPO for ITP in Pregnancy
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Short-course High-dose Prednisone and Dexamethasone in Children With ITP
- Status
- RECRUITING
- Phase
- PHASE4
The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2
The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2
The Expression of Immune Checkpoint CD28 rs1980422-related Single-nucleotide Polymorphisms in the Primary Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- NA
Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2
Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations
- Status
- WITHDRAWN
- Phase
- PHASE2
Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2